RT Book, Section A1 Bounthavong, Mark A1 Nguyen, Christine M. A1 Mendes, Margaret A2 Bertino, Joseph S. A2 DeVane, C. Lindsay A2 Fuhr, Uwe A2 Kashuba, Angela D. A2 Ma, Joseph D. SR Print(0) ID 56876502 T1 Chapter 10. Understanding the Use of Pharmacoeconomic Analysis to Assess the Economic Impact of Pharmacogenomic Testing T2 Pharmacogenomics: An Introduction and Clinical Perspective YR 2013 FD 2013 PB The McGraw-Hill Companies PP New York, NY SN 978-0-07-174169-9 LK accesspharmacy.mhmedical.com/content.aspx?aid=56876502 RD 2024/03/29 AB Define the different elements of pharmacoeconomic analysis: costs, benefits, perspective, cost-effectiveness plane, ECHO model, utility weights and quality-adjusted life years (QALYS), and discounting.Identify the different pharmacoeconomic analyses available: cost-minimization analysis, cost–benefit analysis, cost-effectiveness analysis, and cost–utility analysis.Know the elements of a decision model: decision nodes, chance nodes, and terminal nodes.Identify and interpret the results of a one-way sensitivity analysis, two-way sensitivity analysis, and probabilistic sensitivity analysis, and cost-effectiveness acceptability curve.Determine why pharmacoeconomics is needed when utilizing pharmacogenomics in clinical practice.